NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacyTakahiro Miyazaki, Jonathan Zalevsky, Mekhala Maiti et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 55
Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Nancy Gordon, Vikas Kundra et al.|International Journal of Cancer|2020Cited by 20
Abstract 3755: Comprehensive antitumor immune activation by a novel TLR7/8 targeting agent NKTR-262 combined with CD122-biased immunostimulatory cytokine NKTR-214Saul Kivimäe, Jonathan Zalevsky, Marlene Hennessy et al.|Cancer Research|2018Cited by 19
NKTR-255, a Polymer-Conjugated IL-15 Enhances Antibody-Dependent Cellular Cytotoxicity Mediated By NK Cells in a B Cell Lymphoma ModelTakahiro Miyazaki, Jonathan Zalevsky, Saul Kivimäe et al.|Blood|2019Cited by 5
Abstract 558: Durable antitumor activity of the CD122-biased immunostimulatory cytokine NKTR-214 combined with immune checkpoint blockadeJohn L. Langowski, Deborah H. Charych, Rhoneil Pena et al.|Cancer Research|2016Cited by 2